Chapter 10 of the General Laws is hereby amended by inserting after section 35SSS the following section:-

Section 35TTT. (a) There shall be a Massachusetts Medical Marijuana Research Fund to research the applications of medical marijuana in commonwealth as it relates to treatment for conditions including cancer, amyotrophic lateral sclerosis, Parkinson’s disease, Alzheimer’s disease, HIV/AIDS, epilepsy, seizures, glaucoma and multiple sclerosis, and any other medical conditions identified by the research director of the cannabis control commission. Expenditures from the fund shall be made by the cannabis control commission, without further appropriation and consistent with the terms of settlements made in connection with claims arising from the manufacture, marketing, distribution or dispensing of opioids, as applicable. The research director at the cannabis control commission shall administer the fund, in consultation with the commissioners of the cannabis control commission.

(b) There shall be credited to the fund: (i) $10,000,000 from the Opioid Recovery and Remediation Fund, established in section 35OOO of chapter 10; (ii) transfers from other funds authorized by the general court and so designated; (iii) funds from public or private sources, including, but not limited to, gifts, grants, donations, rebates and settlements received by the commonwealth designated to the fund; and (iv) any interest earned on such amounts. Amounts credited to the fund shall not be subject to further appropriation and monies remaining in the fund at the end of a fiscal year shall not revert to the General Fund.

(c) Biannually, not later than December 31, the research director of the cannabis control commission shall submit a report with the clerks of the house of representatives and the senate.